NCI-H596 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF207
Target Cell Organism: Human
Target Cell Name: NCI-H596
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide NCI-H596-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H596
Target Cell Organism
Human
Target Cell Background
The NCI-H596 cell line was derived by A.F. Gazdar and H. Oie in 1983 from a tumor mass in the chest wall of a patient with adenosquamous carcinoma of the lung. The specimen was obtained prior to therapy.
Related Diseases
Adenosquamous Carcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry